KLP Kapitalforvaltning’s Upstream Bio UPB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-5,900
Closed -$40.8K – 2192
2026
Q2
$40.8K Hold
5,900
– – ﹤0.01% 2132
2026
Q1
$53.1K Buy
5,900
+3,000
+103% +$54K ﹤0.01% 2130
2025
Q4
$78.7K Buy
+2,900
New +$72.2K ﹤0.01% 2116

Other funds holding UPB

KLP Kapitalforvaltning's UPB Position: Q3 2026 in Review

KLP Kapitalforvaltning sold out of Upstream Bio (UPB) in Q3 2026, closing a stake of 5,900 shares — an estimated $40.8K sold.

KLP Kapitalforvaltning first reported a position in UPB in Q4 2025 and held it in 3 quarters. The position peaked at $78.7K in Q4 2025. 135 funds tracked by Wall St. Rank hold UPB as of Q3 2026.

  • KLP Kapitalforvaltning reported no remaining Upstream Bio position as of Q3 2026 after selling out during the quarter.
  • KLP Kapitalforvaltning sold 5,900 Upstream Bio shares in Q3 2026, an estimated $40.8K.
  • KLP Kapitalforvaltning first reported a position in Upstream Bio in Q4 2025 and held it in 3 quarters.
  • KLP Kapitalforvaltning's Upstream Bio position peaked at $78.7K in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Upstream Bio as of Q3 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q3 2026, filed 10 Nov 2026.